Creative Medical Technology Holdings Inc (CELZ)
4.42
+0.08
(+1.84%)
USD |
NASDAQ |
May 17, 16:00
4.42
0.00 (0.00%)
After-Hours: 20:00
Creative Medical Technology Holdings SG&A Expense (Quarterly): 0.6715M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.6715M |
| December 31, 2023 | 1.399M |
| September 30, 2023 | 0.531M |
| June 30, 2023 | 0.8595M |
| March 31, 2023 | 0.771M |
| December 31, 2022 | 0.8996M |
| September 30, 2022 | 0.8055M |
| June 30, 2022 | 1.108M |
| March 31, 2022 | 1.130M |
| December 31, 2021 | 1.428M |
| September 30, 2021 | 0.7572M |
| June 30, 2021 | 0.4983M |
| March 31, 2021 | 0.2809M |
| December 31, 2020 | 0.3158M |
| September 30, 2020 | 0.2851M |
| June 30, 2020 | 0.2149M |
| March 31, 2020 | 0.3462M |
| December 31, 2019 | 0.311M |
| September 30, 2019 | 0.3176M |
| June 30, 2019 | 0.3126M |
| March 31, 2019 | 0.282M |
| December 31, 2018 | 0.2573M |
| September 30, 2018 | 0.2827M |
| June 30, 2018 | 0.3076M |
| March 31, 2018 | 0.2029M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.1501M |
| September 30, 2017 | 0.202M |
| June 30, 2017 | 0.368M |
| March 31, 2017 | 0.1784M |
| December 31, 2016 | 0.1715M |
| September 30, 2016 | 0.1647M |
| June 30, 2016 | 0.1876M |
| March 31, 2016 | 0.1412M |
| December 31, 2015 | 0.0063M |
| September 30, 2015 | 0.0037M |
| June 30, 2015 | 0.0038M |
| March 31, 2015 | 0.007M |
| December 31, 2014 | 0.0042M |
| September 30, 2014 | 0.0036M |
| June 30, 2014 | 0.0036M |
| March 31, 2014 | 0.008M |
| December 31, 2013 | 0.0041M |
| September 30, 2013 | 0.0036M |
| June 30, 2013 | 0.004M |
| March 31, 2013 | 0.0085M |
| December 31, 2012 | 0.0045M |
| September 30, 2012 | 0.0041M |
| June 30, 2012 | 0.0037M |
| March 31, 2012 | 0.0078M |
| December 31, 2011 | 0.0056M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
0.2149M
Minimum
Jun 2020
1.428M
Maximum
Dec 2021
0.6622M
Average
0.6013M
Median
SG&A Expense (Quarterly) Benchmarks
| Avid Bioservices Inc | 6.382M |
| Viking Therapeutics Inc | 9.97M |
| Avinger Inc | 3.837M |
| Aptevo Therapeutics Inc | 3.231M |
| Absci Corp | 8.744M |